The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM‐IV dependence criteria
The DOI matches its Crossref record.
Abstract
DSM‐III‐R and proposed DSM‐IV schemes for the diagnosis of psychoactive substance use disorders art‐based largely mi the dependence syndrome concept. However there is an absence of empirical support for the generalizability of the dependence syndrome across substances, flits study examines how consistently proposed DSM‐IV dependence criteria function to measure dependence across seven substances: alcohol, cannabis, cocaine, stimulants, hallucinogens, sedatives and opiates. Using structured research diagnostic interviews, dependence diagnoses were determined for 295 American subjects in treatment for alcohol/drug problems. Several factor analytic techniques were used la assess whether criteria fanned single dimensions and ham consistently individual criteria measured dependence across substances. The ability and consistency of criteria to measure a continuum of severity across substances were also assessed. Only subjects who used the substance at least six times were entered in the analyses. Overall, results provide strong support fur the DSM approach for alcohol, cannabis, cocaine, stimulants, sedatives and opiates, but not for hallucinogens. Results indicate that a single strong factor adequately described the criteria for these six substances. All criteria loaded strongly and uniformly on single factors indicating that all litre good measures of dependence. Criteria provided a dimensional measure of severity based on several indices for these substances. In addition, four criteria provided relatively stable indicators of high or tow severity across these substances. Results did not support the use of dependence criteria for Hallucinogens as these criteria did not form a single factor. Results suggest that very few hallucinogen users experience an inability to cut down or control use, a key indicator of loss of control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
Psychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343
“Dependence and Diversion There is very limited evidence that psychedelics cause dependence or addiction(Brunton et al., 2011; Morgenstern et al., 1994).”
BackgroundAdverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244
“Hallucinogenic substances structurally similar to DMT are rarely used in a compulsive manner that would meet the dependence criteria of the Diagnostic and Statistical Manual version IV (DSM-IV) [60].”
BackgroundHamill, J., Hallak, J., Dursun, S. M., & Baker, G. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180125095902 · Cited by 178
Metadata
- Authors
- MORGENSTERN, J., LANGENBUCHER, J., & LABOUVIE, E. W.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 1994-09
- Volume
- 89
- Issue
- 9
- Pages
- 1105-1113
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2112854905
- Cited by
- 77
- References
- 0
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM‐IV dependence criteria. https://app.cochat.ai/papers/10.1111/j.1360-0443.1994.tb02787.x
- The paper
- MORGENSTERN, J., LANGENBUCHER, J., & LABOUVIE, E. W. (1994). The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM‐IV dependence criteria. Addiction. https://doi.org/10.1111/j.1360-0443.1994.tb02787.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.